The term life support has been used in scientific publications for almost 60 years. Introduced by scientists at the National Aeronautics and Space Administration to describe technology that maintains life during space missions, life support was initially defined in the context of critical care as “artificial support systems for failing essential organs … [used for] interrupting the death process in a patient who may have a reversible illness.” Currently, life support is defined as “medications or medical devices … [that] support or replace vital organ function on a temporary or permanent basis.” This evolving definition parallels contemporary advances in critical care delivery that have resulted in improved survivorship of critical illness. Yet, these advances have obscured the meaning of life support. Critical care providers possess an array of resources at their disposal that sustain life, yet it is unclear in which contexts use of such resources constitutes an actual use...
Skip Nav Destination
Article navigation
1 November 2022
Evidence-Based Review and Discussion Points|
November 01 2022
Discussion Guide for the Pecanac Article
Grant A. Pignatiello, PhD, RN
Grant A. Pignatiello, PhD, RN
Grant A. Pignatiello is a National Institutes of Health Clinical Research KL2 Scholar and an instructor, Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, Ohio.
Search for other works by this author on:
Am J Crit Care (2022) 31 (6): 469–470.
Citation
Grant A. Pignatiello; Discussion Guide for the Pecanac Article. Am J Crit Care 1 November 2022; 31 (6): 469–470. doi: https://doi.org/10.4037/ajcc2022692
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access
132
Views